Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
As of 2026-04-16, Kazia Therapeutics Limited American Depositary Shares (KZIA) is trading at $10.92 at the time of writing, marking a 9.20% gain on the day. This analysis evaluates key technical levels, recent market context, and potential near-term scenarios for the biotech stock, as no recent earnings data is available for the company as of this publication. The key takeaways include a well-defined near-term support level at $10.37 and resistance level at $11.47, with current momentum tilted t
Kazia (KZIA) Stock MACD Signal (+9.20%) 2026-04-16 - Community Pattern Alerts
KZIA - Stock Analysis
3280 Comments
1519 Likes
1
Makeshia
Influential Reader
2 hours ago
Wish I had noticed this earlier.
👍 14
Reply
Ah, should’ve checked this earlier.
👍 171
Reply
3
Mauwa
Active Contributor
1 day ago
This feels like instructions but I’m not following them.
👍 104
Reply
4
Lakieshia
Legendary User
1 day ago
Well-written and informative — easy to understand key points.
👍 111
Reply
5
Woodensley
Insight Reader
2 days ago
As someone who checks regularly, I’m surprised I missed it.
👍 60
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.